Cargando…

Imbalance between genomic gain and loss identifies high-risk neuroblastoma patients with worse outcomes

Survival in high-risk neuroblastoma (HR-NB) patients remains poor despite multimodal treatment. We aimed to identify HR-NB patients with worse outcomes by analyzing the genomic instability derived from segmental chromosomal aberrations. We calculated 3 genomic instability indexes for primary tumor S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernández-Blanco, Beatriz, Berbegall, Ana Pilar, Martin-Vañó, Susana, Castel, Victoria, Navarro, Samuel, Noguera, Rosa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2020
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674617/ https://www.ncbi.nlm.nih.gov/pubmed/33190090 http://dx.doi.org/10.1016/j.neo.2020.11.001

Ejemplares similares

Intra-Tumour Genetic Heterogeneity and Prognosis in High-Risk Neuroblastoma
por: López-Carrasco, Amparo, et al.
Publicado: (2021)

Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line
por: López-Carrasco, Amparo, et al.
Publicado: (2020)

Neuroblastoma after Childhood: Prognostic Relevance of Segmental Chromosome Aberrations, ATRX Protein Status, and Immune Cell Infiltration()
por: Berbegall, Ana P., et al.
Publicado: (2014)

Genetic Instability and Intratumoral Heterogeneity in Neuroblastoma with MYCN Amplification Plus 11q Deletion
por: Villamón, Eva, et al.
Publicado: (2013)

Extracellular matrix composition defines an ultra-high-risk group of neuroblastoma within the high-risk patient cohort
por: Tadeo, Irene, et al.
Publicado: (2016)

Lymph microvascularization as a prognostic indicator in neuroblastoma
por: Tadeo, Irene, et al.
Publicado: (2018)

Vascular patterns provide therapeutic targets in aggressive neuroblastic tumors
por: Tadeo, Irene, et al.
Publicado: (2016)

A three-dimensional bioprinted model to evaluate the effect of stiffness on neuroblastoma cell cluster dynamics and behavior
por: Monferrer, Ezequiel, et al.
Publicado: (2020)

Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study
por: Berbegall, Ana P., et al.
Publicado: (2018)

Digital Image Analysis Applied to Tumor Cell Proliferation, Aggressiveness, and Migration-Related Protein Synthesis in Neuroblastoma 3D Models
por: Monferrer, Ezequiel, et al.
Publicado: (2020)

Vitronectin as a molecular player of the tumor microenvironment in neuroblastoma
por: Burgos-Panadero, Rebeca, et al.
Publicado: (2019)

How to minimise the effect of tumour cell content in detection of aberrant genetic markers in neuroblastoma
por: Piqueras, M, et al.
Publicado: (2011)

Neuroblastoma patient-derived orthotopic xenografts retain metastatic patterns and geno- and phenotypes of patient tumours
por: Braekeveldt, Noémie, et al.
Publicado: (2015)

The topology of vitronectin: A complementary feature for neuroblastoma risk classification based on computer‐aided detection
por: Vicente‐Munuera, Pablo, et al.
Publicado: (2019)

Two independent epigenetic biomarkers predict survival in neuroblastoma
por: Yáñez, Yania, et al.
Publicado: (2015)

CASP8 SNP D302H (rs1045485) Is Associated with Worse Survival in MYCN-Amplified Neuroblastoma Patients
por: Rihani, Ali, et al.
Publicado: (2014)

Chromosome Imbalances in Neuroblastoma—Recent Molecular Insight into Chromosome 1p-deletion, 2p-gain, and 11q-deletion Identifies New Friends and Foes for the Future
por: Guan, Jikui, et al.
Publicado: (2021)

Clinical Features of Neuroblastoma With 11q Deletion: An Increase in Relapse Probabilities In Localized And 4S Stages
por: J Ribelles, Antonio, et al.
Publicado: (2019)

Publisher Correction: Clinical Features of Neuroblastoma With 11q Deletion: An Increase in Relapse Probabilities In Localized And 4S Stages
por: Juan Ribelles, Antonio, et al.
Publicado: (2020)

Biotensegrity of the Extracellular Matrix: Physiology, Dynamic Mechanical Balance, and Implications in Oncology and Mechanotherapy
por: Tadeo, Irene, et al.
Publicado: (2014)

Gene gain and loss across the Metazoa Tree of Life
por: Fernández, Rosa, et al.
Publicado: (2020)

Distinct evolutionary mechanisms for genomic imbalances in high-risk and low-risk neuroblastomas
por: Gisselsson, David, et al.
Publicado: (2007)

Allelic imbalance on chromosome 5q predicts long-term survival in neuroblastoma.
por: Meltzer, S. J., et al.
Publicado: (1996)

Unfavorable Outcome of Neuroblastoma in Patients With 2p Gain
por: Szewczyk, Katarzyna, et al.
Publicado: (2019)

TIAM1 variants improve clinical outcome in neuroblastoma
por: Sanmartín, Elena, et al.
Publicado: (2017)

Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup
por: Martinez-Monleon, Angela, et al.
Publicado: (2022)

Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
por: Decock, Anneleen, et al.
Publicado: (2012)

Loss & Gain
Publicado: (1879)

Targeting Neuroblastoma Stem Cells with Retinoic Acid and Proteasome Inhibitor
por: Hämmerle, Barbara, et al.
Publicado: (2013)

TNF-α Contributes to Caspase-3 Independent Apoptosis in Neuroblastoma Cells: Role of NFAT
por: Álvarez, Susana, et al.
Publicado: (2011)

Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma
por: Decock, Anneleen, et al.
Publicado: (2015)

Do Mothers Have Worse Sleep Than Fathers? Sleep Imbalance, Parental Stress, and Relationship Satisfaction in Working Parents
por: Härdelin, Göran, et al.
Publicado: (2021)

On identifying risk-adjusted efficiency gains or losses of prospective mergers and acquisitions
por: Tsionas, Mike G., et al.
Publicado: (2022)

Worse and Worse and Worse: Essential Tremor Patients’ Longitudinal Perspectives on Their Condition
por: Gutierrez, Jesús, et al.
Publicado: (2016)

Vitronectin-based hydrogels recapitulate neuroblastoma growth conditions
por: Monferrer, Ezequiel, et al.
Publicado: (2022)

Loss of T-Cell Multifunctionality and TCR-Vβ Repertoire Against Epstein-Barr Virus Is Associated With Worse Prognosis and Clinical Parameters in HIV(+) Patients
por: Hernández, Diana M., et al.
Publicado: (2018)

Weight Gain during Neoadjuvant Chemotherapy is Associated with Worse Outcome among the Patients with Operable Breast Cancer
por: Fang, Qiong, et al.
Publicado: (2019)

Widespread Dysregulation of MiRNAs by MYCN Amplification and Chromosomal Imbalances in Neuroblastoma: Association of miRNA Expression with Survival
por: Bray, Isabella, et al.
Publicado: (2009)

Prosocial Gains and Losses: Modulations of Human Social Decision-Making by Loss-Gain Context
por: Feng, Chunliang, et al.
Publicado: (2021)

Loss of ALK hotspot mutations in relapsed neuroblastoma
por: Allinson, Lisa M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3disbbo6notr778ufkjv1kdcec